Business
Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually
Therma Bright Builds on Revenue Progress with Initial 100-Unit Venowave™ Order; Signals Ex...

About this update from Therma Bright Inc.
[{"type":"text","content":"Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products AnnuallyTherma Bright Builds on Revenue Progress with Initial 100-Unit Venowave™ Order; Signals Expansion into Cosmetic Wellness MarketToronto, Ontario--(Newsfile Corp. - March 31, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) (\"Therma\" or the \"Company\"), a developer and investment partner specializing in advanced diagnostic and medical device technologies, announces it has secured a strategic commercial order for an initial 100 Venowave™ units from Horizon Health (\"Horizon\").This milestone order follows a successful 2025 proof-of-concept phase, during which Therma Bright optimized its delivery and support protocols for the U.S. market. Horizon Health, headquartered in Baltimore, Maryland, is an established leader in durable medical equipment (DME), maintaining deep clinical ties with prestigious institutions including MedStar Health, the University of Maryland, and over 50 specialized surgical centers.Horizon Health manages a robust physician and patient network that currently prescribes over 3,000 compression products per month. This partnership positions Venowave™ to capture a significant share of the high-volume vascular recovery market, both in the Mid-Atlantic region and nationally across the United States.\"Securing this 100-unit order from Horizon Health is a pivotal moment for our commercial scaling strategy,\" stated Rob Fia, CEO of Therma Bright. \"The knowledge gained during our 2025 pilot phase has prepared us to service high-caliber partners like Horizon Health. Their extensive reach into surgical centers and top-tier hospitals provides the perfect launchpad for Venowave™ to become a standard of care in mobile compression.\"James Stadler, Co-CEO of Horizon Health, commented: \"Our doctors and patients demand the most effective, mobile, and patient-compliant solutions for vascular health. Having observed the performance of Venowave™ during the initial evaluation period, we are excited to partner with Therma Bright to integrate this unique technology into our national distribution network, which already services thousands of patients requiring advanced compression therapy every month.\" Steve Ebner, Co-CEO, also commented: \"The continuum of care ...